News & Updates
Filter by Specialty:
Most HF patients do not undergo loop diuretic dose reduction after SGLT2i initiation
19 Dec 2023
Majority of the patients with heart failure (HF) who have initiated treatment with sodium-glucose cotransporter 2 inhibitor (SGLT2i) show no change in loop diuretic dose, reports a study.
Most HF patients do not undergo loop diuretic dose reduction after SGLT2i initiation
19 Dec 2023
Frailty highly prevalent among older hypertensive adults
15 Dec 2023
The prevalence of frailty among older outpatients with hypertension is high, but the agreement between various frailty tools is moderate to weak, according to a study.